Sana Biotechnology Inc
General ticker "SANA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $538.0M
Sana Biotechnology Inc does not follow the US Stock Market performance with the rate: -20.5%.
Estimated limits based on current volatility of 6.6%: low 1.54$, high 1.76$
Factors to consider:
- Current price 39.5% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [2.73$, 6.32$]
- 2024-12-30 to 2025-12-30 estimated range: [3.16$, 7.02$]
Financial Metrics affecting the SANA estimates:
- Negative: Non-GAAP EPS, $ of -1.64 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -24.55 <= 2.35
- Negative: negative Net income
Short-term SANA quotes
Long-term SANA plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $356.91MM | $272.56MM | $326.90MM |
| Operating Income | $-356.91MM | $-272.56MM | $-326.90MM |
| Non-Operating Income | $0.98MM | $3.09MM | $43.65MM |
| R&D Expense | $306.50MM | $201.00MM | $221.64MM |
| Income(Loss) | $-355.93MM | $-269.48MM | $-283.25MM |
| Profit(Loss) | $-355.93MM | $-269.48MM | $-283.25MM |
| Stockholders Equity | $728.50MM | $499.31MM | $287.51MM |
| Assets | $1,129.41MM | $822.72MM | $565.30MM |
| Operating Cash Flow | $-251.05MM | $-290.05MM | $-253.58MM |
| Capital expenditure | $29.86MM | $20.88MM | $20.03MM |
| Investing Cash Flow | $-245.80MM | $210.56MM | $172.01MM |
| Financing Cash Flow | $631.75MM | $4.91MM | $31.65MM |
| Earnings Per Share* | $-2.07 | $-1.41 | $-1.46 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.